YMYoshito Matsui

Yoshito Matsui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshito Matsui has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Natsuo Yasui

    Department of Orthopaedics, Institute of the Health Biosciences, The University of Tokushima Graduate School, Japan

    5 shared publications
  • Hidehiko Kawabata

    3 shared publications
  • Hideki Yoshikawa

    Department of Orthopaedics, Osaka University Graduate School of Medicine, Japan

    2 shared publications
  • Takahiro Kubo

    Department of Orthopaedics, Institute of the Health Biosciences, The University of Tokushima Graduate School, Japan

    2 shared publications
  • Tomohiro Goto

    The University of Tokushima Graduate School

    2 shared publications
  • Akira Myoui

    Department of Orthopaedics, Osaka University Graduate School of Medicine, Japan

    1 shared publication

Latest Publications

  • A novel type of EWS–CHOP fusion gene in myxoid liposarcoma

    by Yoshito Matsui, Takafumi Ueda, Takahiro Kubo, Tadashi Hasegawa, Yasuhiko Tomita, Mina Okamoto, Akira Myoui, Shigeki Kakunaga, Natsuo Yasui, Hideki Yoshikawa


  • The alpha2 type IX collagen tryptophan polymorphism is associated with the severity of disc degeneration in younger patients with herniated nucleus pulposus of the lumbar spine

    by K. Higashino, Y. Matsui, S. Yagi, Y. Takata, T. Goto, T. Sakai, S. Katoh, N. Yasui

    Tryptophan alleles in COL9A2 (Trp2) and COL9A3 (Trp3) have been linked to lumbar disc diseases in the Finnish population. Although such diseases consist of various pathogenetically different conditions, detailed analysis of each has not been well documented. The aim of this study was to clarify whether the collagen IX tryptophan alleles influence the symptomatic degeneration of the lumbar disc in Japanese patients with herniated nucleus pulposus. We performed a prospective study of 84 patients who underwent lumbar discectomy. The degree of disc degeneration was evaluated by magnetic resonance images in relation to the collagen IX genotype. Twenty patients (21.4%) had the Trp2 allele and no patients had the Trp3 allele. Patients under 40 years with the Trp2 allele showed more severe disc degeneration at the surgical level than did those without the Trp2 allele (odds ratio 6.00, P=0.043). In contrast, patients aged 40 years or over did not show significant association between disc degeneration and collagen IX genotype. Our results suggest that the Trp2 allele is an age-dependent risk factor for the severity of disc degeneration in younger patients with symptomatic herniated nucleus pulposus of the lumbar spine. Les allèles tryptophane COL9A2 (Trp2) et COL9A3 (Trp3) ont été chainés à la pathologie discale dans la population finlandaise. Bien que cette pathologie reconnaisse des pathogénies bien différentes, l’analyse détaillée de chacune n’a pas été faite. Le but de cette étude était de clarifier si l’allèle tryptophane du collagène IX influençait la dégénérescence du disque lombaire chez les patients japonais porteurs de hernie discale. Le degré de dégénérescence discale était apprécié par IRM en relation avec leur génotype du collagène IX. Vingt patients (21,4%) avaient l’allèle Trp2 et aucun n’avait le Trp3. Les patients de moins de quarante ans avec le Trp2 avaient une dégénérescence discale plus marquée au niveau opéré que ceux sans l’allèle (odds ratio 6.00, p=0,043). En revanche les patients de plus de quarante ans ne montraient pas d’association entre la dégénérescence et le génotype du collagène IX. Nos résultats suggèrent que l’allèle Trp2 est un facteur de risque âge-dépendant pour l’importance de la dégénérescence discale chez les jeunes patients avec un hernie discale lombaire symptomatique.


  • Intrapatellar tendon lipoma with chondro-osseous differentiation: detection of HMGA2-LPP fusion gene transcript

    by Y Matsui, T Hasegawa, T Kubo, T Goto, K Yukata, K Endo, Y Bando, N Yasui

    A 54 year old man developed an unusual lipoma in the patellar tendon, consisting of a fibro-adipose component and a chondro-osseous component. The fibro-adipose component contained mature adipocytes, lipoblasts, and fibroblasts; the chondro-osseous component showed typical endochondral bone formation. Molecular analysis showed that the identical HMGA2-LPP fusion transcript—characteristic of lipoma, parosteal lipoma, and pulmonary chondroid hamartoma—was detectable in the both components.


  • Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2)

    by Mitsuhiko Takahashi, Yoshito Matsui, Tomohiro Goto, Gen Nishimura, Shiro Ikegawa, Hirofumi Ohashi, Natsuo Yasui


  • The alpha 2 type IX collagen gene tryptophan polymorphism is not associated with rheumatoid arthritis in the Japanese population

    by Yoichiro Takata, Yoshito Matsui, Daisuke Hamada, Tomohiro Goto, Takahiro Kubo, Hiroshi Egawa, Shunji Nakano, Fumio Shinomiya, Hiroshi Inoue, Mitsuo Itakura, et al.

    The aim of this study was to investigate whether the alpha 2 type IX collagen (COL9A2) polymorphism that introduces tryptophan residue into the collagen triple-helix is a marker of susceptibility to, or severity of, rheumatoid arthritis (RA). The study included 749 Japanese patients with RA. One hundred twenty-four unrelated healthy individuals served as the control subjects. The relationship between the COL9A2 gene polymorphism and clinical manifestations of RA was evaluated. For the number of subjects positive for COL9A2 tryptophan polymorphism, there was no statistically significant difference between RA patients and normal controls. Furthermore, we did not detect any association of COL9A2 tryptophan polymorphism with disease status, least erosive subset, more erosive subset, or mutilating disease. The lack of association of COL9A2 tryptophan polymorphism with RA and the clinical findings in our study implies that the polymorphism may not function as a candidate gene marker for screening RA patients.


    • 30 January 2003
      • Vol. 22, 4169-72

    Differential expression of aggrecan mRNA isoforms by chondrosarcoma cells.

    by Yoshito Matsui, Nobuhito Araki, Hideki Tsuboi, Noriyuki Tsumaki, Ken Nakata, Hidehiko Kawabata, David R Eyre, Hideki Yoshikawa

    Aggrecan, the large aggregating proteoglycan, is a major component of the cartilage extracellular matrix. The C-terminal globular domain (G3) of the aggrecan molecule exhibits a pattern of alternative splicing that involves three exons. Each corresponds to a subdomain, epidermal growth factor 1(EGF1), EGF2, and a short complement repeat (SCR). In the present study, we compared aggrecan mRNA splicing variants in osteochondrogenic tumor cells and normal cartilage using RT-PCR. Normal cartilage expressed two mRNA isoforms, both containing the SCR exon, but with or without the EGF1 exon. Benign cartilaginous tumors showed the same splicing pattern as normal cartilage. However, malignant chondrosarcomas expressed additional splicing isoforms, one of which lacked all three alternative exons and another with EGF2 and SCR exons. The human chondrosarcoma cell line (Ch-1 cells) expressed further isoforms, one containing either EGF1 or EGF2 exon only, and another with all the variant exons. These results imply that a change in the pattern of alternative aggrecan mRNA splicing is associated with malignant transformation of chondrocytes.


  • Multiple trigger fingers associated with geleophysic dysplasia

    by Yoshito Matsui, Hidehiko Kawabata, Natsuo Yasui

    We report an infant with geleophysic dysplasia (MIM 231050) who developed multiple trigger fingers. The condition was progressive and distinct from trigger thumb, which is generally seen in infants without any underlying metabolic disease.


  • Skeletal development of achondroplasia: Analysis of genotyped patients

    by Yoshito Matsui, Hidehiko Kawabata, Keiichi Ozono, Natsuo Yasui

    Background : Achondroplasia is a skeletal dysplasia caused by substitution of arginine for glycine at codon 380 (G380R) mutation of the fibroblast growth factor receptor 3. To date, the developmental course of the phenotype (short stature and skeletal characteristics) has not been clarified in the genotyped population. Methods : The relationship between age and clinical data (height, arm span and measurements of skeletal radiographs) were statistically analyzed from 27 achondroplasia patients with the G380R genotype. Results : The height standard deviation score had positive correlation and decreased with age, while span‐to‐height ratio did not. Among measurements of skeletal radiographs, the pelvic index, which represents the squared pelvis deformity, were correlated and increased with age. However, interpedicular distance of the first and fourth lumbar vertebrae (L1:L4) ratio as an index for the caudally narrowed pattern of the lumbar spinal canal and fibula‐to‐tibia ratio for the disproportionally long fibulae were not correlated and did not increase with age. Conclusion : In making a clinical diagnosis of achondroplasia in early infancy, it should be noted that short stature and squared pelvis deformity are not prominent.